Werner H, Heizmann W, Heilmann F
Abteilung Medizinische Mikrobiologie, Hygiene-Institut der Universität, Tübingen.
Arzneimittelforschung. 1988 Jul;38(7):866-8.
Effect of a Combination of Ampicillin and Sulbactam on Clinical Isolates of Anaerobic Bacteria. The antimicrobial susceptibility of 182 recent clinical isolates of anaerobic bacteria to ampicillin alone, ampicillin plus 1 mg/l sulbactam, ampicillin plus 5 mg/l sulbactam, and cefoxitin was studied by means of agar dilution tests. The ampicillin-sulbactam combination (Unacid) was most effective against species of the Bacteroides fragilis group, the MIC90 of ampicillin plus 5 mg/l sulbactam for B. fragilis being less than or equal to 1 mg/l, compared to 256 mg/l of ampicillin, 4 mg/l of ampicillin plus 1 mg/l sulbactam, and 8 mg/l of cefoxitin. No significant difference between ampicillin alone and in combination with sulbactam was observed against gram-positive anaerobic rods or cocci.
氨苄西林与舒巴坦联合用药对厌氧菌临床分离株的影响。通过琼脂稀释试验研究了182株近期厌氧菌临床分离株对单独使用氨苄西林、氨苄西林加1mg/L舒巴坦、氨苄西林加5mg/L舒巴坦以及头孢西丁的抗菌敏感性。氨苄西林 - 舒巴坦联合制剂(优立新)对脆弱拟杆菌群最为有效,氨苄西林加5mg/L舒巴坦对脆弱拟杆菌的MIC90小于或等于1mg/L,相比之下,氨苄西林为256mg/L,氨苄西林加1mg/L舒巴坦为4mg/L,头孢西丁为8mg/L。对于革兰氏阳性厌氧杆菌或球菌,未观察到单独使用氨苄西林与联合舒巴坦之间存在显著差异。